Anti-Infective Agents publishes original research articles, expert reviews, drug clinical trial studies and guest edited issues on all the latest and outstanding developments on the medicinal chemistry, biology, pharmacology and use of anti-infective and anti-parasitic agents. The scope of the journal covers all pre-clinical and clinical research on antimicrobials, antibacterials, antiviral, antifungal, and antiparasitic agents.
Anti-Infective Agents is an essential journal for all infectious disease researchers in industry, academia and the health services.
Articles from the journal Anti-Infective Agents , Volume 14 Issue 2:
- Role of Bactericidal/Permeability-Increasing Protein (BPI) in Sepsis and Liver Cirrhosis, and Its Clinical Implications
- Facing the threat of Antifungal Resistance: Report from the 7th Trends in Medical Mycology (TIMM-7) 9-12 October 2015, Lisbon, Portugal
- Comparative Genomics and Discovery of Novel Cellular Targets for the Development of New Therapeutics Towards Vibrio cholerae, the Causative Agent of Cholera Disease
- Interaction of Complement System Components with Bacterial Outer Membrane Proteins and Presentation of Techniques Useful in Studying these Interactions
- Does the Presence of Multiple Respiratory Pathogens Indicate more Severe Illness in Hospitalized Children?
- Synthesis of Novel Trifluoromethyl Substituted Imidazo Fused Quinolone Analogues and their Antibacterial Activity
- Influence of Hepatitis B Virus Genetic Heterogeneity on Treatment Response Against Lamivudine and Interferon in Pakistani Isolates
- Biological Activities and In Silico Physico-Chemical Properties of 1,2,3- Triazoles Derived from Natural Bioactive Alcohols
- Antiplasmodial Activity and Some Active Compounds from Stachytarpheta cayennensis Vahl. (Verbenaceae) Leaf Fractions
- Synthesis and Antitubercular Evaluation on Novel 1-Ethyl-5-(hetero)aryl- 1,6-dihydropyrazine-2,3-dicarbonitriles and 3-Cyano-1-ethyl-5-(hetero) aryl-2(1H)-pyrazinones
For details on the articles, please visit this link :: http://bit.ly/2d7SBdt